REM-0045392

This study is testing if the medicine REM0045392 is safe and well-tolerated. It also looks at whether food affects how the medicine works.
The medicine will be tested in Healthy men (Part 1 and 2) and Healthy Older men and women (Part 3).
Participants will take the medicine once (in Part 1) or during 10 days (in Part 2 and 3), with increasing doses.
REM0045392 is being developed as a treatment for Alzheimer's disease.